Employers and health insurers struggle to justify wearable health device coverage costs without proven clinical ROI

Payers and employers face pressure to cover expensive wearable devices like the Oura ring ($625M acquisition signals high costs), but lack clear evidence that these devices deliver measurable health outcomes or reduce medical expenses to justify the investment. Current solutions fail because wearables generate data without integrated clinical validation, leaving decision-makers unable to prove ROI to stakeholders and unable to confidently add these to employee/member benefits packages.